Thank you to the panelists of our MRD webinar 2023-10-10. For a recording of the webinar use this link.

Thank you to all participants for taking part in the Nordic AML webinar 2023-11-08. For a recording of the webinar use this link.

We are thrilled to invite you all to the first MNSCT workshop. The program is planned by a scientific committee from the Swedish-Norwegian BMT-group and the Swedish AML-group. The overarching aim of this meeting is to stimulate discussions around topics within the Nordic community. Please register for this event using this link (deadline 2023-10-27). Click here for more […]

Agenda Download a recorded version of the webinar using this link. Find the HCP guide for Ceplene on this link. Ceplene can be ordered with the Nordic item number (Vnr.) 46 54 33, through: Oriola in Sweden TMJ in Denmark Your local wholesaler, Apotek 1, NMD and Alliance in Norway --------------------------------------------- AML patients not candidates to […]

Link and passcode for Teams meeting sent separately. Agenda: Update on potential LD-VenEx amendment trial comparing poDEC/LD-VenEx vs. AZA/LD-VenEx (5 min + 10 min discussion). NAMLG – platform trial structure concept (5 min): Infrastructure with standing collaboration contracts (clinical trial agreement – CTA) and data processing agreements (DPAs) applicable for all types of trials. This […]

Webinar to be held January 25 at 16:00 This is in Standard Biotools’ (former Fluidigm) Scientist in the Spotlight series. More info and registration on this link. Hear about: Insights into AML response: Discover the initial signaling response to standard induction chemotherapy in a cohort of 32 AML patients.   Predicting 5-year survival: Learn about the significant predictors of patient […]

Nordic AML posters at ASH 2023 - Webinar - 2024-03-12 - 15:00-16:20 (CET) Join us for a webinar where we delve into the intricacies of showcased Nordic AML posters at the latest ASH Annual Meeting in December 2023. Here we aim for an opportunity to gain valuable insights, connect with peers, and stay at the […]

Dr. Mika Kontro will discuss the methods for personalizing AML therapies using functional screening. He will provide an overview of the current data implementation and share insights from ongoing prospective trials employing functional screening. Furthermore, Dr. Kontro will focus on the VenEx trial, which utilizes ex vivo drug sensitivity testing to identify AML patients who […]